ANI Pharmaceuticals Inc
Slēgts
SektorsVeselības aprūpe
82.22 -0.36
Pārskats
Akcijas cenas izmaiņa
24h
Min
82.04
Max
83.9
Ienākumi | -61K 27M |
|---|---|
Pārdošana | -9.6M 237M |
P/E Sektora vidējais | 20.609 50.958 |
EPS | 1.68 |
Peļņas marža | 11.551 |
Darbinieki | 970 |
EBITDA | -20M 57M |
Rekomendācijas | Pirkt (spēcīgs) |
|---|---|
Prognoze 12 mēnešiem | +37.81% upside |
Nākamie ieņēmumi | 2026. g. 7. aug. |
|---|
Tirgus kapitalizācija | -41M 1.8B |
|---|---|
Iepriekšējā atvēršanas cena | 82.58 |
Iepriekšējā slēgšanas cena | 82.22 |
Ziņu noskaņojums
By Acuity
50%
50%
146 / 342 Rangs Healthcare
ANI Pharmaceuticals Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Par ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.